Twinge 发表于 2025-3-21 19:13:44

书目名称Management of Prostate Cancer影响因子(影响力)<br>        http://impactfactor.cn/if/?ISSN=BK0622591<br><br>        <br><br>书目名称Management of Prostate Cancer影响因子(影响力)学科排名<br>        http://impactfactor.cn/ifr/?ISSN=BK0622591<br><br>        <br><br>书目名称Management of Prostate Cancer网络公开度<br>        http://impactfactor.cn/at/?ISSN=BK0622591<br><br>        <br><br>书目名称Management of Prostate Cancer网络公开度学科排名<br>        http://impactfactor.cn/atr/?ISSN=BK0622591<br><br>        <br><br>书目名称Management of Prostate Cancer被引频次<br>        http://impactfactor.cn/tc/?ISSN=BK0622591<br><br>        <br><br>书目名称Management of Prostate Cancer被引频次学科排名<br>        http://impactfactor.cn/tcr/?ISSN=BK0622591<br><br>        <br><br>书目名称Management of Prostate Cancer年度引用<br>        http://impactfactor.cn/ii/?ISSN=BK0622591<br><br>        <br><br>书目名称Management of Prostate Cancer年度引用学科排名<br>        http://impactfactor.cn/iir/?ISSN=BK0622591<br><br>        <br><br>书目名称Management of Prostate Cancer读者反馈<br>        http://impactfactor.cn/5y/?ISSN=BK0622591<br><br>        <br><br>书目名称Management of Prostate Cancer读者反馈学科排名<br>        http://impactfactor.cn/5yr/?ISSN=BK0622591<br><br>        <br><br>

蒙太奇 发表于 2025-3-21 23:01:42

http://reply.papertrans.cn/63/6226/622591/622591_2.png

灿烂 发表于 2025-3-22 01:01:42

http://reply.papertrans.cn/63/6226/622591/622591_3.png

burnish 发表于 2025-3-22 04:41:38

http://reply.papertrans.cn/63/6226/622591/622591_4.png

侵蚀 发表于 2025-3-22 11:01:14

http://image.papertrans.cn/m/image/622591.jpg

慢跑鞋 发表于 2025-3-22 13:50:03

Nuclear Medicine (Bone Scan, Choline and PSMA PET/CT),oline PET/CT is not recommended for primary lymph node staging but is a very useful imaging technique in patients with biochemical recurrence, guiding salvage treatments. In this setting, PSMA-based PET imaging has however shown clear superiority and a greater impact on patient management, but large

LEERY 发表于 2025-3-22 19:33:18

Active Surveillance for Low Risk Prostate Cancer,e based on repeat biopsy, imaging, or biomarker results, have shown that this approach is safe in the intermediate to long term, with a 3 % cancer-specific mortality at 10–15 years. Further refinement of the surveillance approach is ongoing, incorporating MRI and targeted biopsies. For patients with

abysmal 发表于 2025-3-23 00:20:13

IMRT, Hypofractionated Radiotherapy and Stereotactic Radiotherapy: Technique, Indications, and Resudeployed in a number of randomised trials and is now regarded as standard practice. The current European Association of Urology guidelines recommend a dose of 76–78 Gy in combination with ADT for intermediate-risk and high-risk disease, when given in ‘standard’ fraction sizes of 1.8–2 Gy per fractio

FICE 发表于 2025-3-23 02:36:32

Combination of Androgen Deprivation Therapy and Radiation Therapy for Locally Advanced and Localizehealth, the recommended treatment is intensity modulated radiotherapy at a dose of 76–80 Gy or a combination of intensity modulated radiotherapy and brachytherapy. The patients need to be informed of the potential morbidity of ADT and a close cooperation is needed with general practitioners and spec

令人作呕 发表于 2025-3-23 07:56:25

http://reply.papertrans.cn/63/6226/622591/622591_10.png
页: [1] 2 3 4 5 6 7
查看完整版本: Titlebook: Management of Prostate Cancer; A Multidisciplinary Michel Bolla,Hendrik van Poppel Book 2017Latest edition Springer International Publishi